Literature DB >> 3905615

Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli.

J E Thole, H G Dauwerse, P K Das, D G Groothuis, L M Schouls, J D van Embden.   

Abstract

A gene bank of Mycobacterium bovis BCG DNA in Escherichia coli was constructed by cloning Sau3A-cleaved mycobacterium DNA fragments into the lambda vector EMBL3. The expression of mycobacterial antigens was analyzed by Western blotting with hyperimmune rabbit sera. Among 770 clones tested, several were found that produced various mycobacterial antigens in low amounts, with concentrations generally close to the detection limit. One particular clone was chosen for further investigation. This clone produced a 64-kilodalton (kDa) antigen. By placing the lambda promoter PL in front of the structural gene of this antigen, an overproducing E. coli strain was obtained. Rocket-line immunoelectrophoresis experiments showed that antigens cross-reacting with the 64-kDa protein are present in a wide variety of mycobacteria and also in so-called purified protein derivatives which are routinely used for skin tests. Preliminary experiments indicate the presence of antibodies against the 64-kDa antigen in sera from tuberculosis patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905615      PMCID: PMC261151          DOI: 10.1128/iai.50.3.800-806.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Screening of cloned recombinant DNA in bacteria by in situ colony hybridization.

Authors:  B Cami; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1978-07       Impact factor: 16.971

2.  The meaning and structure of species as applied to mycobacteria.

Authors:  J L Stanford; J M Grange
Journal:  Tubercle       Date:  1974-06

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies.

Authors:  A R Coates; J Hewitt; B W Allen; J Ivanyi; D A Mitchison
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

Review 5.  Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.

Authors:  T M Daniel; B W Janicki
Journal:  Microbiol Rev       Date:  1978-03

6.  Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda.

Authors:  E Remaut; P Stanssens; W Fiers
Journal:  Gene       Date:  1981-10       Impact factor: 3.688

7.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

8.  The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.

Authors:  O Closs; M Harboe; N H Axelsen; K Bunch-Christensen; M Magnusson
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG.

Authors:  S Nagai; J Matsumoto; T Nagasuga
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Dissection of Mycobacterium tuberculosis antigens using recombinant DNA.

Authors:  R A Young; B R Bloom; C M Grosskinsky; J Ivanyi; D Thomas; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more
  54 in total

Review 1.  Mycobacteria: bugs and bugbears (two steps forward and one step back).

Authors:  T Parish; N G Stoker
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG.

Authors:  M C Lu; M H Lien; R E Becker; H C Heine; A M Buggs; D Lipovsek; R Gupta; P W Robbins; C M Grosskinsky; S C Hubbard
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

3.  Construction of an Escherichia coli-Rhodococcus shuttle vector and plasmid transformation in Rhodococcus spp.

Authors:  M E Singer; W R Finnerty
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

4.  Function and antigen recognition pattern of L3T4+ T-cell clones from Mycobacterium tuberculosis-immune mice.

Authors:  S H Kaufmann; I Flesch
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 5.  Gene manipulation in mycobacteria.

Authors:  J Konícek; M Konícková-Radochová; M Slosárek
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

6.  Immunologic characterization of a 35-kilodalton recombinant antigen of Mycobacterium tuberculosis.

Authors:  H S Rumschlag; M A Yakrus; M L Cohen; S E Glickman; R C Good
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 7.  Techniques for genetic engineering in mycobacteria. Alternative host strains, DNA-transfer systems and vectors.

Authors:  J Hermans; J A de Bont
Journal:  Antonie Van Leeuwenhoek       Date:  1996-04       Impact factor: 2.271

8.  Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens.

Authors:  D B Young; L Kent; R A Young
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

9.  Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages.

Authors:  W E Peetermans; C J Raats; R van Furth; J A Langermans
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12.

Authors:  J E Thole; W J Keulen; J De Bruyn; A H Kolk; D G Groothuis; L G Berwald; R H Tiesjema; J D van Embden
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.